February 2, 2026 · Form 4 insider transaction
Quart Barry D bought 830 shares of Kiniksa Pharmaceuticals Ltd. at $15.47 per share, a transaction worth $12.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.